• Nachrichtendetail
• 

31.05.2024 07:04:41 - dpa-AFX: *REGENERON: FDA EXTENDS TARGET ACTION DATE OF SBLA FOR DUPIXENT FOR COPD PATIENTS WITH TYPE 2 INFLAMMATION BY THREE MONTHS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	REGENERON PHARMAC.DL-,001	881535	Frankfurt	976,600	28.06.24 09:24:09	-16,400	-1,65%	0,000	0,000	976,600	976,600